
Heron Therapeutics, Inc.
USD0.48
-0.00 (-0.67%)
CEO
Craig Alexander Collard
IPO Date
1987-08-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.48
Prev. Close
$0.48
Day Low
$0.46
Day High
$0.49
52W Low
$0.38
52W High
$1.98
Market Cap
$0.08B
Volume
1.51M
Heron Therapeutics Announces Publication Showing Reduction of Pain and Opioid Use Compared to Bupivacaine in Patients 65 and Older with ZYNRELEF™